I decided June as i could not envisage any "predicted " news prior to then and as i am also waiting for fda approval ( covid play ,i relaise delays and fast tracks ),also added a few weeks extra for minor stuff.
just wondering though if we do get more clinical contracts and thus income ( future predicted ) that how high we can get without fda approval
-days till June all rather than trading days !
So what’s the consensus of what could happen prior to June ?
More Clinical Contracts
More Supportive Papers and Data
Either way think it will be a very interesting few months ahead
Worth twitter search , some interesting stuff out there and it looks like we are the horse in the race that’s winning by a few furlongs ( years ) .
Think as given timelines are getting closer lots more interest will happen here , subsequently buying and from this Holding .
I did not expect the recent clinical contract as as it’s been said before excellent news on two fronts firstly an Income and secondly it is that bigger pharma firm are wanting Parsortix to work in unison with their own treatments and procedures .
I am buying at every opportunity!
think a lady godiva could come really suddenly if the right news compounds each other bit ,ie more clinical income ,fda ,nasdaq and hopefully tr1 from big entities buying AFTEr fda approval with sticky hands ,only 213 million shares and for a firm with such possible high it acerbates its potential shareprice .
just bough 817 more so when it shows its definetly a buy
so i also hold GDr and they are also waiting FDA ,EUA approval and looking at the site itself at any one time theres 100,s of firms/products applying for this holy grail ( yes covid has delayed many but it lloks like covid plays are not being given priority and carte blanche ).
so cutting to the crux when do people belive that the next step in fda approval will occur ie delay etc of the full approval and do others envisage a steady but constant clinical income ie new users
Big Oil and Big Pharma tend to gobble up little firms and their products ,and yes small mcap may have been attractive but at what price "could" they have got us for in the recent malaise ?